February 21, 2023

Rudy Tanzi and the Latest Alzheimer’s Drugs - part 1

Rudy Tanzi and the Latest Alzheimer’s Drugs - part 1

About This Episode

Will 2023 be a boom or bust year for new Alzheimer’s drugs? 

In this episode of BrainStorm host Meryl Comer talks with Dr. Rudy Tanzi, Vice-Chair of Neurology at Massachusetts General Hospital, Co-Director of the McCance Center for Brain Health and Professor at Harvard Medical School.  Dr. Tanzi discusses the promising new drugs in a highly charged scientific environment and how these drugs have opened the door to advancement in the treatment of Alzheimer’s. 

Support the show

BrainStorm Feed

52

Mary Lou Falcone - Breaking through the Silence and Stigma of Lewy Body Dementia

Lewy Body Dementia is the second most progressive form of dementia after Alzheimer's and impacts an estimated one mil

LISTEN NOW
51

Leigh Callahan, PhD – Breaking through the Silence and Stigma of Alzheimer’s (part 2)

In this episode of BrainStorm host Meryl Comer continues her care partner conversation with Leigh Callahan, a respected epidemiologist and research

LISTEN NOW
50

Leigh Callahan, PhD - Breaking through the Silence and Stigma of Alzheimer’s (part 1)

The care partner is the keeper of the secrets and their perspective is essential to break through the silence and stigma of Alzheimer’s disease.

LISTEN NOW